Paixão, P.; Silva, N.; Guerreiro, R.B.; Blake, K.; Bonelli, M.; Morais, J.A.G.; García-Arieta, A.; Gouveia, L.F.
Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics 2022, 14, 2349.
https://doi.org/10.3390/pharmaceutics14112349
AMA Style
Paixão P, Silva N, Guerreiro RB, Blake K, Bonelli M, Morais JAG, García-Arieta A, Gouveia LF.
Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics. 2022; 14(11):2349.
https://doi.org/10.3390/pharmaceutics14112349
Chicago/Turabian Style
Paixão, Paulo, Nuno Silva, Rita Bento Guerreiro, Kevin Blake, Milton Bonelli, José Augusto Guimarães Morais, Alfredo García-Arieta, and Luís Filipe Gouveia.
2022. "Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union" Pharmaceutics 14, no. 11: 2349.
https://doi.org/10.3390/pharmaceutics14112349
APA Style
Paixão, P., Silva, N., Guerreiro, R. B., Blake, K., Bonelli, M., Morais, J. A. G., García-Arieta, A., & Gouveia, L. F.
(2022). Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics, 14(11), 2349.
https://doi.org/10.3390/pharmaceutics14112349
